IMRT

Long term clinical outcomes of IMRT in NSCLC

Update of the MD Anderson experience: 165 patients 2005-2006 66Gy in 33fx Median survival 21.6 months Esophageal Tox G3 G2: 70% G3: 18% - 7/29 stricture Lung Tox G3: 11% 6m; 14% 12m Lung Tox G2

Lung Tox G1: at 18m 86%

Jiang ZQ, IJRBOP 2012; 83: 332-339